Logo Carenity
Logo Carenity
Join now! Log in
flag en
flag fr flag es flag de flag it flag us
Home Forum Conditions Magazine Medications Surveys
Join now! Log in
  • Forum
  • Conditions
  • Magazine
  • Medications
  • Surveys
  • Home
  • Forums
  • General forums
  • Research and useful tips - Multiple Sclerosis
  • £6m statin trial raises hope drug can be used to treat multiple sclerosis
 Back
Research and useful tips - Multiple Sclerosis

£6m statin trial raises hope drug can be used to treat multiple sclerosis

  •  4 views
  •  0 support
  •  1 comment

avatar Margarita_k

Margarita_k

Community manager
15/05/2017 at 18:45

Good advisor

avatar Margarita_k

Margarita_k

Community manager

Last activity on 07/10/2020 at 11:39

Joined in 2016


1,195 comments posted | 88 in the Research and useful tips - Multiple Sclerosis group

2 of their responses were helpful to members


Rewards

  • Good Advisor

  • Contributor

  • Messenger

  • Committed

  • Explorer

  • Evaluator


 View profileView  Add a friendAdd  Write
Trial involving almost 1,200 people aims to ‘establish definitively’ whether cholesterol drug can slow disability progression

Scientists are hopeful a major drug trial will establish that statins can be used to treat multiple sclerosis.

The low-cost drugs are typically prescribed to help lower levels of “bad cholesterol” associated with raised risk of a heart attack or stroke, but they have also shown “incredible promise” for the treatment of MS.

A small study – involving 140 people – published in the Lancet in 2014 on patients with secondary progressive MS, found those taking high doses of simvastatin had a significant reduction in the rate of brain atrophy over two years and also had better disability scores at the end of study.

The new trial will be much larger, involving 1,180 people, and will aim to establish whether the drug can slow disability progression. The £6m project has funding from the National Institute for Health Research, the charities MS Society UK and National MS Society (US), as well as from the NHS and British universities.

Dr Jeremy Chataway, of the UCL Institute of Neurology, who led the 2014 trial, will also be at the helm for the new study.

He said: “This drug [simvastatin] holds incredible promise for the thousands of people living with secondary progressive MS in the UK, and around the world, who currently have few options for treatments that have an effect on disability. This study will establish definitively whether simvastatin is able to slow the rate of disability progression over a three-year period, and we are very hopeful it will.”

More than 100,000 people in the UK have MS, which attacks the central nervous system. Symptoms usually start when a person is in their 20s and 30s and it affects almost three times as many women as men. It can be painful and exhausting and can cause problems with walking, moving, thought, memory and emotions.

Most of those diagnosed have relapsing MS and about 65% of these cases develop secondary progressive MS, usually within 15 years. There are currently no licensed treatments that can slow or stop disability progression in people with secondary progressive MS.

Michelle Mitchell, chief executive of the MS Society, said the research would offer “a huge amount of hope”. She added: “This is a momentous step forward in our quest to find an effective treatment for progressive MS.”

Statins are estimated to prevent about 80,000 strokes and heart attacks a year in the UK but critics questioned the safety and efficacy of the drugs after NHS guidelines advised that prescriptions should be extended to those at lower risk of heart disease. Research published this month suggests the common side-effects of statins are a result of patients’ negative expectations rather than the drugs themselves.

Simvastatin is the most commonly used of the anti-cholesterol drugs. In the 2014 trial, patients were given 80mg doses, which would cost about 7p a day.

Stuart Nixon, who lives with secondary progressive MS, said: “At the moment people like me are living with the prospect of our condition getting worse each day. This is the most exciting opportunity to change how we manage progressive MS. It would be amazing if this trial can show that an existing drug, costing just a few pence a day, can help with MS.”



The Guardian
Follow

Other groups...

All things Christmas
Carenity News
Feedback for Carenity
Fun and games
Good to know
How to use Carenity
Let's talk about COVID-19
Life beyond illness
News from the media
Procedures and Paperwork
Youth patients with chronic conditions

Give your opinion

Survey

What do you think about the Carenity Forum and community?

All comments

avatar exit

Unregistered member

17/05/2017 at 17:43

nice to know they are on the right path!


£6m statin trial raises hope drug can be used to treat multiple sclerosis https://www.carenity.co.uk/forum/other-discussions/my-library-multiple-sclerosis/6m-statin-trial-raises-hope-drug-can-be-used-t-1741 2017-05-17 17:43:02

Give your opinion

Survey

What do you think about the Carenity Forum and community?

Articles to discover...

The fear of flare-ups: How to stop waiting for the worst and take back control

23/05/2025 | Advice

The fear of flare-ups: How to stop waiting for the worst and take back control

The identity shift: How to build a life that includes, but isn’t defined by, illness

05/05/2025 | Advice

The identity shift: How to build a life that includes, but isn’t defined by, illness

Medications and driving: Are your prescriptions putting you at risk behind the wheel?

26/04/2025 | Advice

Medications and driving: Are your prescriptions putting you at risk behind the wheel?

Can journaling bring real benefits for chronic illness symptoms?

25/04/2025 | Advice

Can journaling bring real benefits for chronic illness symptoms?

NHS - Get help with prescription costs

12/11/2019 | Procedures & paperwork

NHS - Get help with prescription costs

Diclofenac to become a prescription drug

21/01/2015 | News

Diclofenac to become a prescription drug

Opioids Causing Concerns, Problems for Chronic Pain Patients

14/10/2016 | News

Opioids Causing Concerns, Problems for Chronic Pain Patients

Do you have the winter blues?

21/10/2014 | News

Do you have the winter blues?

icon cross

Does this topic interest you?

Join the 500 000 patients registered on our platform, get information on your condition or on that of your family member, and discuss it with the community

Join now! Join now! Join now! Join now! Join now!

It’s free and confidential

Subscribe

You wish to be notified of new comments

 

Your subscription has been taken into account

Join now! Log in

About

  • Who are we?
  • The Carenity team
  • The Science and Ethics Committee
  • Contributors
  • Carenity in the news
  • Certifications and awards
  • Data For Good
  • Our scientific publications
  • Discover our studies
  • Editorial policy
  • Code of conduct
  • Our commitments
  • Legal notice
  • Terms of use
  • Cookies management
  • Contact
  • Carenity for professionals

Quick access

  • Health magazine
  • Search a forum
  • Learn about a condition
  • See medication reviews
  • List of forums (A-Z)
  • List of condition info sheets (A-Z)
  • List of medication fact sheets (A-Z)
  • Language flag fr flag de flag es flag it flag us

The www.carenity.co.uk website does not constitute or replace professional medical advice.